The global GMP Tumor Necrosis Factor Alpha market was valued at US$ 29 million in 2023 and is anticipated to reach US$ 52 million by 2030, witnessing a CAGR of 8.8% during the forecast period 2024-2030.

GMP Tumor Necrosis Factor Alpha Market

Tumor necrosis factor alpha (TNF-α) is a cytokine that plays a central role in inflammation, immune system development, apoptosis, and lipid metabolism. It is mainly produced by monocytes and macrophages as a response to infection, injury, or tumor burden. TNF-α can also be produced from a range of other cell types such as T cells, natural killer cells (NK cells) and neutrophils.

A significant driver in the GMP Tumor Necrosis Factor Alpha (TNF-α) market is the increasing use of TNF-α as a therapeutic target in various inflammatory and autoimmune diseases. TNF-α plays a pivotal role in regulating inflammation, and drugs targeting this molecule have shown efficacy in conditions like rheumatoid arthritis and inflammatory bowel diseases. However, a notable challenge in this market is the need for stringent quality control and compliance with Good Manufacturing Practices (GMP). Ensuring that TNF-α production processes meet the highest standards of quality, safety, and purity while adhering to regulatory requirements poses a significant challenge. Manufacturers must invest in robust GMP-compliant manufacturing processes, quality assurance, and regulatory compliance to deliver safe and effective TNF-α-based therapeutics, meeting the increasing demand for innovative treatments in the field of immunology and inflammation.

This report aims to provide a comprehensive presentation of the global market for GMP Tumor Necrosis Factor Alpha, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GMP Tumor Necrosis Factor Alpha.

Report Scope

The GMP Tumor Necrosis Factor Alpha market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global GMP Tumor Necrosis Factor Alpha market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the GMP Tumor Necrosis Factor Alpha companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of GMP Tumor Necrosis Factor Alpha Market Report

Report Metric	Details
Report Name	GMP Tumor Necrosis Factor Alpha Market
Accounted market size in 2023	US$ 29 million
Forecasted market size in 2030	US$ 52 million
CAGR	8.8%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	25μg 50μg Others
Segment by Application	Cell/Gene Therapy Tissue-Engineered Products Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Miltenyi Biotec, Bio-Techne, GE Healthcare, Lonza, CellGenix, ReproCELL, PeproTech, Sino Biological, Creative Bioarray, Akron Biotech, Almog
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of GMP Tumor Necrosis Factor Alpha companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is GMP Tumor Necrosis Factor Alpha Market growing?

Ans: The GMP Tumor Necrosis Factor Alpha Market witnessing a CAGR of 8.8% during the forecast period 2024-2030.

What is the GMP Tumor Necrosis Factor Alpha Market size in 2030?

Ans: The GMP Tumor Necrosis Factor Alpha Market size in 2030 will be US$ 52 million.

Who are the main players in the GMP Tumor Necrosis Factor Alpha Market report?

Ans: The main players in the GMP Tumor Necrosis Factor Alpha Market are Miltenyi Biotec, Bio-Techne, GE Healthcare, Lonza, CellGenix, ReproCELL, PeproTech, Sino Biological, Creative Bioarray, Akron Biotech, Almog

What are the Application segmentation covered in the GMP Tumor Necrosis Factor Alpha Market report?

Ans: The Applications covered in the GMP Tumor Necrosis Factor Alpha Market report are Cell/Gene Therapy, Tissue-Engineered Products, Others

What are the Type segmentation covered in the GMP Tumor Necrosis Factor Alpha Market report?

Ans: The Types covered in the GMP Tumor Necrosis Factor Alpha Market report are 25μg, 50μg, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global GMP Tumor Necrosis Factor Alpha Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 25μg

1.2.3 50μg

1.2.4 Others

1.3 Market by Application

1.3.1 Global GMP Tumor Necrosis Factor Alpha Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Cell/Gene Therapy

1.3.3 Tissue-Engineered Products

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global GMP Tumor Necrosis Factor Alpha Market Perspective (2019-2030)

2.2 GMP Tumor Necrosis Factor Alpha Growth Trends by Region

2.2.1 Global GMP Tumor Necrosis Factor Alpha Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 GMP Tumor Necrosis Factor Alpha Historic Market Size by Region (2019-2024)

2.2.3 GMP Tumor Necrosis Factor Alpha Forecasted Market Size by Region (2025-2030)

2.3 GMP Tumor Necrosis Factor Alpha Market Dynamics

2.3.1 GMP Tumor Necrosis Factor Alpha Industry Trends

2.3.2 GMP Tumor Necrosis Factor Alpha Market Drivers

2.3.3 GMP Tumor Necrosis Factor Alpha Market Challenges

2.3.4 GMP Tumor Necrosis Factor Alpha Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top GMP Tumor Necrosis Factor Alpha Players by Revenue

3.1.1 Global Top GMP Tumor Necrosis Factor Alpha Players by Revenue (2019-2024)

3.1.2 Global GMP Tumor Necrosis Factor Alpha Revenue Market Share by Players (2019-2024)

3.2 Global GMP Tumor Necrosis Factor Alpha Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by GMP Tumor Necrosis Factor Alpha Revenue

3.4 Global GMP Tumor Necrosis Factor Alpha Market Concentration Ratio

3.4.1 Global GMP Tumor Necrosis Factor Alpha Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by GMP Tumor Necrosis Factor Alpha Revenue in 2023

3.5 GMP Tumor Necrosis Factor Alpha Key Players Head office and Area Served

3.6 Key Players GMP Tumor Necrosis Factor Alpha Product Solution and Service

3.7 Date of Enter into GMP Tumor Necrosis Factor Alpha Market

3.8 Mergers & Acquisitions, Expansion Plans

4 GMP Tumor Necrosis Factor Alpha Breakdown Data by Type

4.1 Global GMP Tumor Necrosis Factor Alpha Historic Market Size by Type (2019-2024)

4.2 Global GMP Tumor Necrosis Factor Alpha Forecasted Market Size by Type (2025-2030)

5 GMP Tumor Necrosis Factor Alpha Breakdown Data by Application

5.1 Global GMP Tumor Necrosis Factor Alpha Historic Market Size by Application (2019-2024)

5.2 Global GMP Tumor Necrosis Factor Alpha Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America GMP Tumor Necrosis Factor Alpha Market Size (2019-2030)

6.2 North America GMP Tumor Necrosis Factor Alpha Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America GMP Tumor Necrosis Factor Alpha Market Size by Country (2019-2024)

6.4 North America GMP Tumor Necrosis Factor Alpha Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe GMP Tumor Necrosis Factor Alpha Market Size (2019-2030)

7.2 Europe GMP Tumor Necrosis Factor Alpha Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe GMP Tumor Necrosis Factor Alpha Market Size by Country (2019-2024)

7.4 Europe GMP Tumor Necrosis Factor Alpha Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific GMP Tumor Necrosis Factor Alpha Market Size (2019-2030)

8.2 Asia-Pacific GMP Tumor Necrosis Factor Alpha Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific GMP Tumor Necrosis Factor Alpha Market Size by Region (2019-2024)

8.4 Asia-Pacific GMP Tumor Necrosis Factor Alpha Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America GMP Tumor Necrosis Factor Alpha Market Size (2019-2030)

9.2 Latin America GMP Tumor Necrosis Factor Alpha Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America GMP Tumor Necrosis Factor Alpha Market Size by Country (2019-2024)

9.4 Latin America GMP Tumor Necrosis Factor Alpha Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa GMP Tumor Necrosis Factor Alpha Market Size (2019-2030)

10.2 Middle East & Africa GMP Tumor Necrosis Factor Alpha Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa GMP Tumor Necrosis Factor Alpha Market Size by Country (2019-2024)

10.4 Middle East & Africa GMP Tumor Necrosis Factor Alpha Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Miltenyi Biotec

11.1.1 Miltenyi Biotec Company Detail

11.1.2 Miltenyi Biotec Business Overview

11.1.3 Miltenyi Biotec GMP Tumor Necrosis Factor Alpha Introduction

11.1.4 Miltenyi Biotec Revenue in GMP Tumor Necrosis Factor Alpha Business (2019-2024)

11.1.5 Miltenyi Biotec Recent Development

11.2 Bio-Techne

11.2.1 Bio-Techne Company Detail

11.2.2 Bio-Techne Business Overview

11.2.3 Bio-Techne GMP Tumor Necrosis Factor Alpha Introduction

11.2.4 Bio-Techne Revenue in GMP Tumor Necrosis Factor Alpha Business (2019-2024)

11.2.5 Bio-Techne Recent Development

11.3 GE Healthcare

11.3.1 GE Healthcare Company Detail

11.3.2 GE Healthcare Business Overview

11.3.3 GE Healthcare GMP Tumor Necrosis Factor Alpha Introduction

11.3.4 GE Healthcare Revenue in GMP Tumor Necrosis Factor Alpha Business (2019-2024)

11.3.5 GE Healthcare Recent Development

11.4 Lonza

11.4.1 Lonza Company Detail

11.4.2 Lonza Business Overview

11.4.3 Lonza GMP Tumor Necrosis Factor Alpha Introduction

11.4.4 Lonza Revenue in GMP Tumor Necrosis Factor Alpha Business (2019-2024)

11.4.5 Lonza Recent Development

11.5 CellGenix

11.5.1 CellGenix Company Detail

11.5.2 CellGenix Business Overview

11.5.3 CellGenix GMP Tumor Necrosis Factor Alpha Introduction

11.5.4 CellGenix Revenue in GMP Tumor Necrosis Factor Alpha Business (2019-2024)

11.5.5 CellGenix Recent Development

11.6 ReproCELL

11.6.1 ReproCELL Company Detail

11.6.2 ReproCELL Business Overview

11.6.3 ReproCELL GMP Tumor Necrosis Factor Alpha Introduction

11.6.4 ReproCELL Revenue in GMP Tumor Necrosis Factor Alpha Business (2019-2024)

11.6.5 ReproCELL Recent Development

11.7 PeproTech

11.7.1 PeproTech Company Detail

11.7.2 PeproTech Business Overview

11.7.3 PeproTech GMP Tumor Necrosis Factor Alpha Introduction

11.7.4 PeproTech Revenue in GMP Tumor Necrosis Factor Alpha Business (2019-2024)

11.7.5 PeproTech Recent Development

11.8 Sino Biological

11.8.1 Sino Biological Company Detail

11.8.2 Sino Biological Business Overview

11.8.3 Sino Biological GMP Tumor Necrosis Factor Alpha Introduction

11.8.4 Sino Biological Revenue in GMP Tumor Necrosis Factor Alpha Business (2019-2024)

11.8.5 Sino Biological Recent Development

11.9 Creative Bioarray

11.9.1 Creative Bioarray Company Detail

11.9.2 Creative Bioarray Business Overview

11.9.3 Creative Bioarray GMP Tumor Necrosis Factor Alpha Introduction

11.9.4 Creative Bioarray Revenue in GMP Tumor Necrosis Factor Alpha Business (2019-2024)

11.9.5 Creative Bioarray Recent Development

11.10 Akron Biotech

11.10.1 Akron Biotech Company Detail

11.10.2 Akron Biotech Business Overview

11.10.3 Akron Biotech GMP Tumor Necrosis Factor Alpha Introduction

11.10.4 Akron Biotech Revenue in GMP Tumor Necrosis Factor Alpha Business (2019-2024)

11.10.5 Akron Biotech Recent Development

11.11 Almog

11.11.1 Almog Company Detail

11.11.2 Almog Business Overview

11.11.3 Almog GMP Tumor Necrosis Factor Alpha Introduction

11.11.4 Almog Revenue in GMP Tumor Necrosis Factor Alpha Business (2019-2024)

11.11.5 Almog Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

List of Tables

Table 1. Global GMP Tumor Necrosis Factor Alpha Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of 25μg

Table 3. Key Players of 50μg

Table 4. Key Players of Others

Table 5. Global GMP Tumor Necrosis Factor Alpha Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global GMP Tumor Necrosis Factor Alpha Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global GMP Tumor Necrosis Factor Alpha Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global GMP Tumor Necrosis Factor Alpha Market Share by Region (2019-2024)

Table 9. Global GMP Tumor Necrosis Factor Alpha Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global GMP Tumor Necrosis Factor Alpha Market Share by Region (2025-2030)

Table 11. GMP Tumor Necrosis Factor Alpha Market Trends

Table 12. GMP Tumor Necrosis Factor Alpha Market Drivers

Table 13. GMP Tumor Necrosis Factor Alpha Market Challenges

Table 14. GMP Tumor Necrosis Factor Alpha Market Restraints

Table 15. Global GMP Tumor Necrosis Factor Alpha Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global GMP Tumor Necrosis Factor Alpha Market Share by Players (2019-2024)

Table 17. Global Top GMP Tumor Necrosis Factor Alpha Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GMP Tumor Necrosis Factor Alpha as of 2023)

Table 18. Ranking of Global Top GMP Tumor Necrosis Factor Alpha Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by GMP Tumor Necrosis Factor Alpha Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players GMP Tumor Necrosis Factor Alpha Product Solution and Service

Table 22. Date of Enter into GMP Tumor Necrosis Factor Alpha Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global GMP Tumor Necrosis Factor Alpha Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global GMP Tumor Necrosis Factor Alpha Revenue Market Share by Type (2019-2024)

Table 26. Global GMP Tumor Necrosis Factor Alpha Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global GMP Tumor Necrosis Factor Alpha Revenue Market Share by Type (2025-2030)

Table 28. Global GMP Tumor Necrosis Factor Alpha Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global GMP Tumor Necrosis Factor Alpha Revenue Market Share by Application (2019-2024)

Table 30. Global GMP Tumor Necrosis Factor Alpha Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global GMP Tumor Necrosis Factor Alpha Revenue Market Share by Application (2025-2030)

Table 32. North America GMP Tumor Necrosis Factor Alpha Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America GMP Tumor Necrosis Factor Alpha Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America GMP Tumor Necrosis Factor Alpha Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe GMP Tumor Necrosis Factor Alpha Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe GMP Tumor Necrosis Factor Alpha Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe GMP Tumor Necrosis Factor Alpha Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific GMP Tumor Necrosis Factor Alpha Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific GMP Tumor Necrosis Factor Alpha Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific GMP Tumor Necrosis Factor Alpha Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America GMP Tumor Necrosis Factor Alpha Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America GMP Tumor Necrosis Factor Alpha Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America GMP Tumor Necrosis Factor Alpha Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa GMP Tumor Necrosis Factor Alpha Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa GMP Tumor Necrosis Factor Alpha Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa GMP Tumor Necrosis Factor Alpha Market Size by Country (2025-2030) & (US$ Million)

Table 47. Miltenyi Biotec Company Detail

Table 48. Miltenyi Biotec Business Overview

Table 49. Miltenyi Biotec GMP Tumor Necrosis Factor Alpha Product

Table 50. Miltenyi Biotec Revenue in GMP Tumor Necrosis Factor Alpha Business (2019-2024) & (US$ Million)

Table 51. Miltenyi Biotec Recent Development

Table 52. Bio-Techne Company Detail

Table 53. Bio-Techne Business Overview

Table 54. Bio-Techne GMP Tumor Necrosis Factor Alpha Product

Table 55. Bio-Techne Revenue in GMP Tumor Necrosis Factor Alpha Business (2019-2024) & (US$ Million)

Table 56. Bio-Techne Recent Development

Table 57. GE Healthcare Company Detail

Table 58. GE Healthcare Business Overview

Table 59. GE Healthcare GMP Tumor Necrosis Factor Alpha Product

Table 60. GE Healthcare Revenue in GMP Tumor Necrosis Factor Alpha Business (2019-2024) & (US$ Million)

Table 61. GE Healthcare Recent Development

Table 62. Lonza Company Detail

Table 63. Lonza Business Overview

Table 64. Lonza GMP Tumor Necrosis Factor Alpha Product

Table 65. Lonza Revenue in GMP Tumor Necrosis Factor Alpha Business (2019-2024) & (US$ Million)

Table 66. Lonza Recent Development

Table 67. CellGenix Company Detail

Table 68. CellGenix Business Overview

Table 69. CellGenix GMP Tumor Necrosis Factor Alpha Product

Table 70. CellGenix Revenue in GMP Tumor Necrosis Factor Alpha Business (2019-2024) & (US$ Million)

Table 71. CellGenix Recent Development

Table 72. ReproCELL Company Detail

Table 73. ReproCELL Business Overview

Table 74. ReproCELL GMP Tumor Necrosis Factor Alpha Product

Table 75. ReproCELL Revenue in GMP Tumor Necrosis Factor Alpha Business (2019-2024) & (US$ Million)

Table 76. ReproCELL Recent Development

Table 77. PeproTech Company Detail

Table 78. PeproTech Business Overview

Table 79. PeproTech GMP Tumor Necrosis Factor Alpha Product

Table 80. PeproTech Revenue in GMP Tumor Necrosis Factor Alpha Business (2019-2024) & (US$ Million)

Table 81. PeproTech Recent Development

Table 82. Sino Biological Company Detail

Table 83. Sino Biological Business Overview

Table 84. Sino Biological GMP Tumor Necrosis Factor Alpha Product

Table 85. Sino Biological Revenue in GMP Tumor Necrosis Factor Alpha Business (2019-2024) & (US$ Million)

Table 86. Sino Biological Recent Development

Table 87. Creative Bioarray Company Detail

Table 88. Creative Bioarray Business Overview

Table 89. Creative Bioarray GMP Tumor Necrosis Factor Alpha Product

Table 90. Creative Bioarray Revenue in GMP Tumor Necrosis Factor Alpha Business (2019-2024) & (US$ Million)

Table 91. Creative Bioarray Recent Development

Table 92. Akron Biotech Company Detail

Table 93. Akron Biotech Business Overview

Table 94. Akron Biotech GMP Tumor Necrosis Factor Alpha Product

Table 95. Akron Biotech Revenue in GMP Tumor Necrosis Factor Alpha Business (2019-2024) & (US$ Million)

Table 96. Akron Biotech Recent Development

Table 97. Almog Company Detail

Table 98. Almog Business Overview

Table 99. Almog GMP Tumor Necrosis Factor Alpha Product

Table 100. Almog Revenue in GMP Tumor Necrosis Factor Alpha Business (2019-2024) & (US$ Million)

Table 101. Almog Recent Development

Table 102. Research Programs/Design for This Report

Table 103. Key Data Information from Secondary Sources

Table 104. Key Data Information from Primary Sources

List of Figures

Figure 1. Global GMP Tumor Necrosis Factor Alpha Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global GMP Tumor Necrosis Factor Alpha Market Share by Type: 2023 VS 2030

Figure 3. 25μg Features

Figure 4. 50μg Features

Figure 5. Others Features

Figure 6. Global GMP Tumor Necrosis Factor Alpha Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global GMP Tumor Necrosis Factor Alpha Market Share by Application: 2023 VS 2030

Figure 8. Cell/Gene Therapy Case Studies

Figure 9. Tissue-Engineered Products Case Studies

Figure 10. Others Case Studies

Figure 11. GMP Tumor Necrosis Factor Alpha Report Years Considered

Figure 12. Global GMP Tumor Necrosis Factor Alpha Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 13. Global GMP Tumor Necrosis Factor Alpha Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 14. Global GMP Tumor Necrosis Factor Alpha Market Share by Region: 2023 VS 2030

Figure 15. Global GMP Tumor Necrosis Factor Alpha Market Share by Players in 2023

Figure 16. Global Top GMP Tumor Necrosis Factor Alpha Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in GMP Tumor Necrosis Factor Alpha as of 2023)

Figure 17. The Top 10 and 5 Players Market Share by GMP Tumor Necrosis Factor Alpha Revenue in 2023

Figure 18. North America GMP Tumor Necrosis Factor Alpha Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 19. North America GMP Tumor Necrosis Factor Alpha Market Share by Country (2019-2030)

Figure 20. United States GMP Tumor Necrosis Factor Alpha Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Canada GMP Tumor Necrosis Factor Alpha Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe GMP Tumor Necrosis Factor Alpha Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe GMP Tumor Necrosis Factor Alpha Market Share by Country (2019-2030)

Figure 24. Germany GMP Tumor Necrosis Factor Alpha Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. France GMP Tumor Necrosis Factor Alpha Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. U.K. GMP Tumor Necrosis Factor Alpha Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Italy GMP Tumor Necrosis Factor Alpha Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Russia GMP Tumor Necrosis Factor Alpha Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Nordic Countries GMP Tumor Necrosis Factor Alpha Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific GMP Tumor Necrosis Factor Alpha Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific GMP Tumor Necrosis Factor Alpha Market Share by Region (2019-2030)

Figure 32. China GMP Tumor Necrosis Factor Alpha Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Japan GMP Tumor Necrosis Factor Alpha Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. South Korea GMP Tumor Necrosis Factor Alpha Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Southeast Asia GMP Tumor Necrosis Factor Alpha Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. India GMP Tumor Necrosis Factor Alpha Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Australia GMP Tumor Necrosis Factor Alpha Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America GMP Tumor Necrosis Factor Alpha Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America GMP Tumor Necrosis Factor Alpha Market Share by Country (2019-2030)

Figure 40. Mexico GMP Tumor Necrosis Factor Alpha Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Brazil GMP Tumor Necrosis Factor Alpha Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa GMP Tumor Necrosis Factor Alpha Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa GMP Tumor Necrosis Factor Alpha Market Share by Country (2019-2030)

Figure 44. Turkey GMP Tumor Necrosis Factor Alpha Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Saudi Arabia GMP Tumor Necrosis Factor Alpha Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Miltenyi Biotec Revenue Growth Rate in GMP Tumor Necrosis Factor Alpha Business (2019-2024)

Figure 47. Bio-Techne Revenue Growth Rate in GMP Tumor Necrosis Factor Alpha Business (2019-2024)

Figure 48. GE Healthcare Revenue Growth Rate in GMP Tumor Necrosis Factor Alpha Business (2019-2024)

Figure 49. Lonza Revenue Growth Rate in GMP Tumor Necrosis Factor Alpha Business (2019-2024)

Figure 50. CellGenix Revenue Growth Rate in GMP Tumor Necrosis Factor Alpha Business (2019-2024)

Figure 51. ReproCELL Revenue Growth Rate in GMP Tumor Necrosis Factor Alpha Business (2019-2024)

Figure 52. PeproTech Revenue Growth Rate in GMP Tumor Necrosis Factor Alpha Business (2019-2024)

Figure 53. Sino Biological Revenue Growth Rate in GMP Tumor Necrosis Factor Alpha Business (2019-2024)

Figure 54. Creative Bioarray Revenue Growth Rate in GMP Tumor Necrosis Factor Alpha Business (2019-2024)

Figure 55. Akron Biotech Revenue Growth Rate in GMP Tumor Necrosis Factor Alpha Business (2019-2024)

Figure 56. Almog Revenue Growth Rate in GMP Tumor Necrosis Factor Alpha Business (2019-2024)

Figure 57. Bottom-up and Top-down Approaches for This Report

Figure 58. Data Triangulation

Figure 59. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-33S12067

Fri Oct 11 00:00:00 UTC 2024

Add to Cart

Metastatic Bone Tumor Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-6T7647

Tue Oct 08 00:00:00 UTC 2024

Add to Cart

Anti-Oral Mucositis Drug - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-5V5924

Mon Oct 07 00:00:00 UTC 2024

Add to Cart

Transarterial Chemoembolization (TACE) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-18Y13983

Mon Oct 07 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global GMP Tumor Necrosis Factor Alpha Market Research Report 2024

Published Date: January 2024

Report Code: QYRE-Auto-8K6014

Global GMP Tumor Necrosis Factor Alpha Market Research Report 2024

FEATURED COMPANIES

GMP Tumor Necrosis Factor Alpha Market Size

GMP Tumor Necrosis Factor Alpha Market

Report Scope

Scope of GMP Tumor Necrosis Factor Alpha Market Report

Chapter Outline

FAQ for this report

How fast is GMP Tumor Necrosis Factor Alpha Market growing?

What is the GMP Tumor Necrosis Factor Alpha Market size in 2030?

Who are the main players in the GMP Tumor Necrosis Factor Alpha Market report?

What are the Application segmentation covered in the GMP Tumor Necrosis Factor Alpha Market report?

What are the Type segmentation covered in the GMP Tumor Necrosis Factor Alpha Market report?

FEATURED COMPANIES

RELATED REPORTS